Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2014 by Children's Hospital Boston
Sponsor:
Collaborators:
Progeria Research Foundation
Schering-Plough
Information provided by (Responsible Party):
Mark Kieran, Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT00916747
First received: June 5, 2009
Last updated: August 7, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2017
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)
No publications provided by Children's Hospital Boston

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):